NasdaqCM - Delayed Quote USD

Heart Test Laboratories, Inc. (HSCS)

0.0974 -0.0025 (-2.50%)
At close: April 26 at 4:00 PM EDT
0.0988 +0.00 (+1.44%)
After hours: April 26 at 7:21 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Andrew Simpson CEO, President & Chairman of the Board of Directors 264.14k -- 1970
Ms. Danielle Watson CFO & Treasurer 188.75k -- 1983
Mr. Mark T. Hilz COO, Secretary & Director 263.61k -- 1959

Heart Test Laboratories, Inc.

550 Reserve Street
Suite 360
Southlake, TX 76092
United States
682 237 7781 https://heartsciences.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
12

Description

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Corporate Governance

Heart Test Laboratories, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Mar 14, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Mar 12, 2024
    CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
    See Full Filing
  • Mar 05, 2024
    S-1: Offering Registrations
    See Full Filing
  • Feb 26, 2024
    S-8: Offering Registrations
    See Full Filing
  • Feb 15, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing

Upcoming Events

Related Tickers

SINT Sintx Technologies, Inc.
0.0404
+10.38%
 
NUWE Nuwellis, Inc.
0.1678
-41.94%
 
RSLS ReShape Lifesciences Inc.
0.1698
-4.61%
 
DYNT Dynatronics Corporation
0.5549
-3.53%
 
BIOL BIOLASE, Inc.
0.1480
0.00%
 
INVO INVO Bioscience, Inc.
0.9800
-0.01%
 
VTAK Catheter Precision, Inc.
0.5472
-0.50%
 
INBS Intelligent Bio Solutions Inc.
2.6900
+8.03%
 
BSGM BioSig Technologies, Inc.
1.3700
+5.38%
 
TBIO Telesis Bio, Inc.
0.3184
-3.89%